The Biotherapies Institute has privileged access to two structures, bioproduction and quality control, essential to successfully carry out the clinical development of innovative therapies.
Genethon Bioprod: production of viral vectors to GMP standards
Genethon has a bioproduction centre, Genethon Bioprod, which from 2012 will offer a production capacity of gene therapy products of a clinical grade never achieved.
Its mission: produce gene therapy treatments for clinical trials conducted in France or abroad with the strictest compliance to regulatory requirements of pharmaceutical products.
GenoSafe: evaluation of the efficacy and safety of biotherapeutic products
Created by the AFM-Telethon and Genethon, GenoSafe is a services company specialised in the evaluation of the efficacy and safety of biotherapeutic products.
From the different research stages to clinical studies, GenoSafe offers support in study design, development and validation of trials, in compliance with regulatory requirements.
